Vitamin d and its role in cancer and immunity: a prescription for sunlight (Q36824458)

16 August 2017

1 reference

title

Vitamin d and its role in cancer and immunity: a prescription for sunlight (English)

1 reference

16 August 2017

0 references

1

Gerard E Mullin

1 reference

16 August 2017

Adrian Dobs

2

1 reference

PubMed ID

17507731

16 August 2017

language of work or name

1 reference

1 June 2007

1 reference

Nutrition in Clinical Practice

16 August 2017

1 reference

16 August 2017

22

1 reference

16 August 2017

3

1 reference

16 August 2017

305-322

1 reference

Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health

16 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Vitamin D and prevention of breast cancer: pooled analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Plasma 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D and Risk of Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma skin cancer: a composite death certificate based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

A multicountry ecologic study of risk and risk reduction factors for prostate cancer mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Sunlight, vitamin D, and ovarian cancer mortality rates in US women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

The role of vitamin D in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Colon cancer and solar ultraviolet B radiation and prevention and treatment of colon cancer in mice with vitamin D and its Gemini analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Molecular analysis of p21 promoter activity isolated from squamous carcinoma cell lines of the head and neck under the influence of 1,25(OH)2 vitamin D3 and its analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Vitamin D: its role in cancer prevention and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Vitamin D, calcium, and breast cancer risk: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Dietary intake of selected micronutrients and breast-cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Dairy, calcium, and vitamin D intake and postmenopausal breast cancer risk in the Cancer Prevention Study II Nutrition Cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Diet and premenopausal bilateral breast cancer: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Intake of dairy products, calcium, and vitamin d and risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Prediagnostic serum vitamin D and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Prospective Study of Predictors of Vitamin D Status and Cancer Incidence and Mortality in Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Sun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

The role of vitamin D in cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Vitamin D Status and Cancer Incidence and Mortality: Something New Under the Sun

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Commentary: vitamin D and colorectal cancer--twenty-five years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Linoleic acid, vitamin D and other nutrient intakes in the risk of non-Hodgkin lymphoma: an Italian case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Vitamin D intake and the risk for pancreatic cancer in two cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Vitamin D3 and vitamin D3 analogues as an adjunct to cancer chemo-therapy and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Nutrient regulation of cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Vitamin D growth inhibition of breast cancer cells: gene expression patterns assessed by cDNA microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

1α,25-Dihydroxycholecalciferol and a human myeloid leukaemia cell line (HL-60)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Autocrine TGFbeta signaling mediates vitamin D3 analog-induced growth inhibition in breast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Antiproliferative action of vitamin D-related compounds and insulin-like growth factor-binding protein 5 accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Profiling 1,25-dihydroxyvitamin D3-regulated gene expression by microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Vitamin D enhances caspase-dependent and -independent TNFalpha-induced breast cancer cell death: The role of reactive oxygen species and mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Detailed molecular understanding of agonistic and antagonistic vitamin D receptor ligands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Development of weekly high-dose calcitriol based therapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

High-dose calcitriol and carboplatin in metastatic androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

A phase II trial of the vitamin D analogue Seocalcitol (EB1089) in patients with inoperable pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

High dose pulse calcitriol, docetaxel and estramustine for androgen independent prostate cancer: a phase I/II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Pharmacokinetics of high-dose oral calcitriol: results from a phase 1 trial of calcitriol and paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

A phase one study of the hepatic arterial administration of 1,25-dihydroxyvitamin D3 for liver cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

A phase I study of the vitamin D analogue EB 1089 in patients with advanced breast and colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Effects of Seocalcitol (EB1089) on Nitrosomethyl Urea-Induced Rat Mammary Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Chemoprevention of chemically-induced mammary and colon carcinogenesis by 1alpha-hydroxyvitamin D5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Novel nonsecosteroidal vitamin D receptor modulator inhibits the growth of LNCaP xenograft tumors in athymic mice without increased serum calcium

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

1,25-Dihydroxy-16-ene-23-yne-vitamin D3 and prostate cancer cell proliferation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Inhibition of prostate cancer-meditated osteoblastic bone lesions by the low-calcemic analog 1alpha-hydroxymethyl-16-ene-26,27-bishomo-25-hydroxy vitamin D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Inhibition of MG-63 cell cycle progression by synthetic vitamin D3 analogs mediated by p27, Cdk2, cyclin E, and the retinoblastoma protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Effect of 20-epi-1alpha,25-dihydroxyvitamin D3 on the proliferation of human neuroblastoma: role of cell cycle regulators and the Myc-Id2 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Histometric assessment of psoriatic plaques treated by vitamin D3 derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

1alpha,25-dihydroxyvitamin D(3) (calcitriol) and its analogue, 19-nor-1alpha,25(OH)(2)D(2), potentiate the effects of ionising radiation on human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Effects of FK228, a novel histone deacetylase inhibitor, on human lymphoma U-937 cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

A Crucial Role for the Vitamin D Receptor in Experimental Inflammatory Bowel Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Rag-1-dependent cells are necessary for 1,25-dihydroxyvitamin D(3) prevention of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Redirection of human autoreactive T-cells Upon interaction with dendritic cells modulated by TX527, an analog of 1,25 dihydroxyvitamin D(3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

1-alpha,25-Dihydroxyvitamin D3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Inflammatory bowel disease (1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Inflammatory bowel disease (2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Inflammatory bowel disease and osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Generation and analysis of interleukin-4 deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Vitamin D intake and incidence of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Vitamin D and autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

1,25-Dihydroxyvitamin D3 restores sensitivity to cyclophosphamide-induced apoptosis in non-obese diabetic (NOD) mice and protects against diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Prevention of autoimmune destruction of syngeneic islet grafts in spontaneously diabetic nonobese diabetic mice by a combination of a vitamin D3 analog and cyclosporine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

A unique point mutation in the human vitamin D receptor chromosomal gene confers hereditary resistance to 1,25-dihydroxyvitamin D3

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Vitamin D receptor polymorphisms and diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Vitamin D receptor genotypes in primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Haplotype analysis of VDR gene polymorphisms: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Meta-analysis of molecular association studies: vitamin D receptor gene polymorphisms and BMD as a case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Vitamin D receptor gene polymorphisms and prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

No association between androgen or vitamin D receptor gene polymorphisms and risk of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Association of the vitamin D receptor genotype with bone metastases in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Vitamin D receptor gene polymorphisms and breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Vitamin D receptor gene polymorphisms are associated with breast cancer risk in a UK Caucasian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Vitamin D receptor polymorphisms and risk of colorectal adenomas (United States).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Association of vitamin D receptor gene BsmI polymorphisms in Chinese patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Vitamin D receptor gene polymorphism: association with Crohn's disease susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Genetic association of vitamin D receptor polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Variation in the vitamin D receptor gene is associated with multiple sclerosis in an Australian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Susceptibility and outcome in MS: associations with polymorphisms in pigmentation-related genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Prevalence of vitamin D insufficiency in an adult normal population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Prevalence of vitamin D deficiency among healthy adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

A high prevalence of hypovitaminosis D in Finnish medical in- and outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Redefining vitamin D insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Adolescent Girls in Maine Are at Risk for Vitamin D Insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Pilot study: potential role of vitamin D (Cholecalciferol) in patients with PSA relapse after definitive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Adolescent diet and risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Vitamin D receptor polymorphisms as markers in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

Vitamin D and Reduced Risk of Breast Cancer: A Population-Based Case-Control Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426507022003305

10.1177/0115426507022003305

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference

PubMed ID

17507731